New Frontiers: Clinical Potential of Emerging Signaling Pathway Inhibitors for Glioma

imedex has 1202 videos Subscribe Here

Description: To see the full interview go to

Dr Tracy Batchelor interviews Dr Mark Gilbert about the science of angiogenesis and why vascular endothelial growth factor (VEGF) is an important target in the treatment of glioblastoma. They review clinical trial data around varied signaling pathway inhibitor agents that have been studied and are currently under investigation in the management of this deadly cancer
Shared By : imedex
Posted on : 08/26/10
Added : 7 years ago
Category : General


Nothing found.